Grifols, S.A. (GRFS)
NASDAQ: GRFS · Real-Time Price · USD
7.45
-0.08 (-1.06%)
At close: Feb 21, 2025, 4:00 PM
7.50
+0.05 (0.67%)
After-hours: Feb 21, 2025, 4:53 PM EST
Grifols Employees
Grifols had 23,737 employees as of December 31, 2023. The number of employees decreased by 2,577 or -9.79% compared to the previous year.
Employees
23,737
Change (1Y)
-2,577
Growth (1Y)
-9.79%
Revenue / Employee
$329,195
Profits / Employee
$7,588
Market Cap
6.02B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 23,737 | -2,577 | -9.79% |
Dec 31, 2022 | 26,314 | 3,080 | 13.26% |
Dec 31, 2021 | 23,234 | -421 | -1.78% |
Dec 31, 2020 | 23,655 | -348 | -1.45% |
Dec 31, 2019 | 24,003 | 2,773 | 13.06% |
Dec 31, 2018 | 21,230 | 2,934 | 16.04% |
Dec 31, 2017 | 18,296 | 3,419 | 22.98% |
Dec 31, 2016 | 14,877 | 140 | 0.95% |
Dec 31, 2015 | 14,737 | 757 | 5.41% |
Dec 31, 2014 | 13,980 | 2,201 | 18.69% |
Dec 31, 2013 | 11,779 | 671 | 6.04% |
Dec 31, 2012 | 11,108 | -122 | -1.09% |
Dec 31, 2011 | 11,230 | 5,262 | 88.17% |
Dec 31, 2010 | 5,968 | -16 | -0.27% |
Dec 31, 2009 | 5,984 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
GRFS News
- 16 days ago - Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition - GlobeNewsWire
- 5 weeks ago - Grifols Pioneers High-Tech Analysis of Plasma Bank to Detect Early Signs of Parkinson's Disease - GlobeNewsWire
- 5 weeks ago - Mason Capital complains about Grifols' transparency to Spanish regulator - Reuters
- 5 weeks ago - Mason Capital Management Sends Letter to Spanish National Securities Market Commission Regarding Lack of Transparency by Grifols - Business Wire
- 2 months ago - Flat Footed Calls for Prompt Governance Overhaul at Grifols - Business Wire
- 2 months ago - Spain's market regulator sees signs of manipulation in Grifols-Gotham dispute - Reuters
- 2 months ago - Mason Capital Management Requests Immediate Disclosure of Important Information Regarding Conflicted Grifols Director Tomas Daga - Business Wire
- 2 months ago - Statement From Araoz y Rueda on Behalf of Certain Institutional Investors in Grifols - Business Wire